Related Experiment Video
Updated: Oct 7, 2025

Analysis of Endocytic Uptake and Retrograde Transport to the Trans-Golgi Network Using Functionalized Nanobodies in Cultured Cells
Published on: February 21, 2019
Golgi Alpha1,2-Mannosidase IA Promotes Efficient Endoplasmic Reticulum-Associated Degradation of NKCC2
Sylvie Demaretz1,2, Elie Seaayfan1,2, Dalal Bakhos-Douaihy1,2
1Centre de Recherche des Cordeliers, Sorbonne Université, Inserm, Université de Paris, F-75006 Paris, France.
Abstract:
Mutations in the apically located kidney Na-K-2Cl cotransporter NKCC2 cause type I Bartter syndrome, a life-threatening kidney disorder. We previously showed that transport from the ER represents the limiting phase in NKCC2 journey to the cell surface. Yet very little is known about the ER quality control components specific to NKCC2 and its disease-causing mutants. Here, we report the identification of Golgi alpha1, 2-mannosidase IA (ManIA) as a novel binding partner of the immature form of NKCC2. ManIA interaction with NKCC2 takes place mainly at the cis-Golgi network. ManIA coexpression decreased total NKCC2 protein abundance whereas ManIA knock-down produced the opposite effect. Importantly, ManIA coexpression had a more profound effect on NKCC2 folding mutants. Cycloheximide chase assay showed that in cells overexpressing ManIA, NKCC2 stability and maturation are heavily hampered. Deleting the cytoplasmic region of ManIA attenuated its interaction with NKCC2 and inhibited its effect on the maturation of the cotransporter. ManIA-induced reductions in NKCC2 expression were offset by the proteasome inhibitor MG132. Likewise, kifunensine treatment greatly reduced ManIA effect, strongly suggesting that mannose trimming is involved in the enhanced ERAD of the cotransporter. Moreover, depriving ManIA of its catalytic domain fully abolished its effect on NKCC2. In summary, our data demonstrate the presence of a ManIA-mediated ERAD pathway in renal cells promoting retention and degradation of misfolded NKCC2 proteins. They suggest a model whereby Golgi ManIA contributes to ERAD of NKCC2, by promoting the retention, recycling, and ERAD of misfolded proteins that initially escape protein quality control surveillance within the ER.
Insights
Golgi alpha1, 2-mannosidase IA (ManIA) targets misfolded kidney Na-K-2Cl cotransporter (NKCC2) for degradation. This ManIA-mediated pathway enhances ER-associated degradation (ERAD) of NKCC2 mutants, crucial for type I Bartter syndrome.
Area of Science:
- Cell Biology
- Molecular Biology
- Renal Physiology
Background:
- Mutations in NKCC2 cause type I Bartter syndrome, a severe kidney disorder.
- ER transport is a rate-limiting step for NKCC2 maturation.
- ER quality control mechanisms for NKCC2 and its mutants are poorly understood.
Purpose of the Study:
- Identify novel ER quality control components interacting with NKCC2.
- Investigate the role of Golgi alpha1, 2-mannosidase IA (ManIA) in NKCC2 maturation and degradation.
- Elucidate the mechanism of ManIA-mediated ER-associated degradation (ERAD) of NKCC2.
Main Methods:
- Co-immunoprecipitation to identify binding partners.
- Western blotting to assess protein abundance.
- Cycloheximide chase assays to study protein stability.
- Mutagenesis to investigate functional domains of ManIA.
- Treatment with proteasome inhibitors and mannosidase inhibitors.
Main Results:
- ManIA binds to immature NKCC2 at the cis-Golgi network.
- ManIA coexpression reduces total NKCC2 levels, particularly folding mutants.
- ManIA accelerates NKCC2 degradation via the proteasome pathway.
- ManIA's catalytic activity and cytoplasmic tail are essential for its effect on NKCC2 maturation.
Conclusions:
- ManIA is a novel binding partner of NKCC2.
- ManIA mediates an ERAD pathway that promotes the degradation of misfolded NKCC2.
- This pathway involves mannose trimming and proteasomal degradation.
- ManIA plays a critical role in renal cell quality control of NKCC2, impacting Bartter syndrome pathogenesis.
Related Concept Videos
Export of Misfolded Proteins out of the ER
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
Golgi Apparatus
Protein Folding Quality Check in the RER
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

